1-3 of 3
C. McAlister
Close
Sort by
Journal Articles

Recombinant Activated Factor VII (rFVIIa) in the Treatment of Non-Hemophilia Patients: Physician Underreporting of Thromboembolic Adverse Events.

Cyrus C. Hsia, MD, FRCPC, Joanna H. Zurawska, Michael Z.Y. Tong, MD, Kathleen Eckert, MLT, ART, Vivian C. McAlister, MD, FRCSC, Ian H. Chin-Yee, MD, FRCPC
Journal: Blood
Blood (2007) 110 (11): 3143.
https://doi.org/10.1182/blood.V110.11.3143.3143
Published: 2007
Journal Articles

A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.

Paul Richardson, A. Chanan-Khan, R. Schlossman, N. Munshi, P. Wen, H. Briemberg, D. Kuter, A. Oaklander, S. Lonial, H. Hassoun, D. Doss, L. Lunde, S. Hayes, M. McKenney, K. Hande, L. Lai, A. Freeman, K. Dinand, C. McAlister, D. Warren, D. Collins, D. Esseltine, A. Amato, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 2548.
https://doi.org/10.1182/blood.V106.11.2548.2548
Published: 2005
Journal Articles

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy

Peng H. Tan, Sven C. Beutelspacher, Shao-An Xue, Yao-He Wang, Peter Mitchell, James C. McAlister, D. Frank P. Larkin, Myra O. McClure, Hans J. Stauss, Mary A. Ritter, Giovanna Lombardi, Andrew J. T. George
Journal: Blood
Blood (2005) 105 (10): 3824–3832.
https://doi.org/10.1182/blood-2004-10-3880
Published: 2005
Includes: Supplemental data